Skip to main content
Erschienen in: Journal of General Internal Medicine 14/2022

03.01.2022 | Original Research

Frailty and Survival After In-Hospital Cardiopulmonary Resuscitation

verfasst von: Frances Y. Hu, MD, MSc, Shoshana Streiter, MD, Lynne O’Mara, MPAS, PA-C, Stephanie M. Sison, MD, MBA, Olga Theou, PhD, Rachelle Bernacki, MD, MS, Ariela Orkaby, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 14/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Older adults face high mortality following resuscitation efforts for in-hospital cardiac arrest. Less is known about the role of frailty in survival to discharge after in-hospital cardiopulmonary resuscitation.

Objective

To investigate whether frailty, measured by the Clinical Frailty Scale, is associated with mortality after cardiopulmonary resuscitation following in-hospital cardiac arrest in older adults in the USA.

Design

Retrospective cohort study.

Participants

Patients ≥ 65 years who had undergone cardiopulmonary resuscitation during an inpatient admission at two urban academic hospitals and three suburban community hospitals within a Boston area healthcare system from January 2018-January 2020. Patients with Clinical Frailty Scale scores 1–3 were considered not frail, 4–6 were considered very mildly, mildly, and moderately frail, respectively, and 7–9 were considered severely frail.

Main Measures

In-hospital mortality after cardiopulmonary resuscitation.

Key Results

Among 324 patients who underwent cardiopulmonary resuscitation following in-hospital cardiac arrest, 73.1% experienced in-hospital mortality. Patients with a Clinical Frailty Scale score of 1–3 had 54% in-hospital mortality, which increased to 66%, 78%, 84%, and 84% for those with a Clinical Frailty Scale score of 4, 5, 6, and 7–9, respectively (p = 0.001). After adjusting for age, sex, race, and Charlson Comorbidity Index, higher frailty scores were significantly associated with higher odds of in-hospital mortality. Compared to those with a Clinical Frailty Scale score of 1–3, odds ratios (95% CI) for in-hospital mortality for patients with a Clinical Frailty Scale score of 4, 5, 6, and 7–9 were 1.6 (0.8–3.3), 3.0 (1.3–7.1), 4.4 (1.9–9.9), and 4.6 (1.8–11.8), respectively (p = 0.001).

Conclusions

Higher levels of frailty are associated with increased mortality after in-hospital cardiopulmonary resuscitation in older adults. Clinicians may consider using the Clinical Frailty Scale to help guide goals of care conversations, including discussion of code status, in this patient population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
18.
Zurück zum Zitat Nalichowski R, Keogh D, Chueh HC, Murphy SN. Calculating the benefits of a Research Patient Data Repository. AMIA Annual Symposium proceedings AMIA Symposium. 2006;2006:1044-1044.PubMedCentral Nalichowski R, Keogh D, Chueh HC, Murphy SN. Calculating the benefits of a Research Patient Data Repository. AMIA Annual Symposium proceedings AMIA Symposium. 2006;2006:1044-1044.PubMedCentral
27.
Zurück zum Zitat Van Gijn MS, Frijns D, Van De Glind EMM, C. Van Munster B, Hamaker ME. The chance of survival and the functional outcome after in-hospital cardiopulmonary resuscitation in older people: a systematic review. Age and Ageing. 2014–07–01 2014;43(4):456–463. https://doi.org/10.1093/ageing/afu035 Van Gijn MS, Frijns D, Van De Glind EMM, C. Van Munster B, Hamaker ME. The chance of survival and the functional outcome after in-hospital cardiopulmonary resuscitation in older people: a systematic review. Age and Ageing. 2014–07–01 2014;43(4):456–463. https://​doi.​org/​10.​1093/​ageing/​afu035
30.
Zurück zum Zitat Hayashi T, Matsushima M, Bito S, et al. Predictors Associated with Survival Among Elderly In-Patients Who Receive Cardiopulmonary Resuscitation in Japan: An Observational Cohort Study. Journal of General Internal Medicine. 2019–02–01 2019;34(2):206–210. https://doi.org/10.1007/s11606-018-4747-5 Hayashi T, Matsushima M, Bito S, et al. Predictors Associated with Survival Among Elderly In-Patients Who Receive Cardiopulmonary Resuscitation in Japan: An Observational Cohort Study. Journal of General Internal Medicine. 2019–02–01 2019;34(2):206–210. https://​doi.​org/​10.​1007/​s11606-018-4747-5
31.
Zurück zum Zitat Fletcher JWA, Smith A, Walsh K, Riddick A. Low Rates of Survival Seen in Orthopedic Patients Receiving In-Hospital Cardiopulmonary Resuscitation. Geriatric Orthopaedic Surgery & Rehabilitation. 2019–01–01 2019;10:215145931881897. https://doi.org/10.1177/2151459318818972 Fletcher JWA, Smith A, Walsh K, Riddick A. Low Rates of Survival Seen in Orthopedic Patients Receiving In-Hospital Cardiopulmonary Resuscitation. Geriatric Orthopaedic Surgery & Rehabilitation. 2019–01–01 2019;10:215145931881897. https://​doi.​org/​10.​1177/​2151459318818972​
35.
Zurück zum Zitat Greenwald JL, Greer JA, Gace D, et al. Implementing Automated Triggers to Identify Hospitalized Patients with Possible Unmet Palliative Needs: Assessing the Impact of This Systems Approach on Clinicians. Journal of Palliative Medicine. 2020–11–01 2020;23(11):1500–1506. https://doi.org/10.1089/jpm.2020.0161 Greenwald JL, Greer JA, Gace D, et al. Implementing Automated Triggers to Identify Hospitalized Patients with Possible Unmet Palliative Needs: Assessing the Impact of This Systems Approach on Clinicians. Journal of Palliative Medicine. 2020–11–01 2020;23(11):1500–1506. https://​doi.​org/​10.​1089/​jpm.​2020.​0161
43.
Zurück zum Zitat Pranata R, Henrina J, Lim MA, et al. Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis. Archives of gerontology and geriatrics. 2020:104324. Pranata R, Henrina J, Lim MA, et al. Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis. Archives of gerontology and geriatrics. 2020:104324.
44.
Zurück zum Zitat Clayton JM, Butow PN, Arnold RM, Tattersall MH. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Supportive Care in Cancer. 2005;13(9):733-742.CrossRef Clayton JM, Butow PN, Arnold RM, Tattersall MH. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Supportive Care in Cancer. 2005;13(9):733-742.CrossRef
45.
Zurück zum Zitat O'Mara L, Streiter S, Orkaby AR, Ouchi K, Bernacki R. A Framework to Triage Older Adults with Covid-19 to Provide Patient-Centered Care. 2020. Nov 5 2020. doi:10.1056 O'Mara L, Streiter S, Orkaby AR, Ouchi K, Bernacki R. A Framework to Triage Older Adults with Covid-19 to Provide Patient-Centered Care. 2020. Nov 5 2020. doi:10.1056
Metadaten
Titel
Frailty and Survival After In-Hospital Cardiopulmonary Resuscitation
verfasst von
Frances Y. Hu, MD, MSc
Shoshana Streiter, MD
Lynne O’Mara, MPAS, PA-C
Stephanie M. Sison, MD, MBA
Olga Theou, PhD
Rachelle Bernacki, MD, MS
Ariela Orkaby, MD, MPH
Publikationsdatum
03.01.2022
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 14/2022
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-021-07199-1

Weitere Artikel der Ausgabe 14/2022

Journal of General Internal Medicine 14/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.